UPB
Upstream Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
+9.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 116.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.75x
- Price / sales
- 64.17x
- Price / cash flow
- -1.49x
Enterprise value
- Enterprise value
- -$57.7M
- EV / sales
- -18.27x
- EV / EBITDA
- 0.37x
- EV / EBIT
- 0.34x
- Market cap
- $202.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026